Examkin

Soru

Zorluk: OrtaEndocrinology and Metabolism

A 27-year-old woman comes to the clinic for a routine health maintenance examination. Her mother was recently diagnosed with Hashimoto thyroiditis, and the patient requested a thyroid evaluation to ensure her own thyroid function is normal. She reports feeling well and has no specific complaints. She has normal energy levels, regular menstrual cycles, and no changes in weight, heat intolerance, or palpitations. Her only medications are a daily multivitamin and an over-the-counter supplement she started 2 months ago to improve the thickness of her hair and nails. Vital signs are within normal limits. Physical examination reveals a normal-sized, non-tender thyroid gland without palpable nodules. There is no tremor, and her skin is warm and dry. Laboratory testing shows:

Laboratory TestResultReference Range
Thyroid-stimulating hormone (TSH)0.02 mU/L0.4–4.0 mU/L
Free thyroxine (T4)2.8 ng/dL0.9–2.4 ng/dL
Total triiodothyronine (T3)220 ng/dL80–200 ng/dL

Which of the following is the most appropriate next step in management?

  1. Instruct the patient to discontinue the hair and nail supplement and repeat the laboratory testsCevap
  2. B
    Order a radioactive iodine uptake and scan of the thyroid gland
  3. C
    Measure serum thyrotropin receptor antibodies
  4. D
    Initiate pharmacologic therapy with methimazole
  5. E
    Perform ultrasonography of the thyroid gland

Cevap

Instruct the patient to discontinue the hair and nail supplement and repeat the laboratory tests
The correct answer is to instruct the patient to discontinue her hair and nail supplement and repeat the laboratory tests. This patient presents with a classic scenario for assay interference: a stark discrepancy between a completely asymptomatic, clinically euthyroid presentation and laboratory results indicating severe primary hyperthyroidism (suppressed TSH, elevated free T4 and T3). The key clue in her history is the recent initiation of an over-the-counter supplement for hair and nails. These supplements frequently contain high doses of biotin (vitamin B7). Many modern thyroid function tests utilize streptavidin-biotin technology in their assays. High levels of circulating exogenous biotin competitively bind to the streptavidin in the assay, interfering with the results. In 'sandwich' assays used for TSH, exogenous biotin prevents the formation of the measurable complex, leading to a falsely low TSH signal. In 'competitive' assays used for free T4 and T3, excess biotin prevents the binding of the labeled analog, which the assay reads as a high level of endogenous hormone. This perfectly mimics the biochemical profile of primary hyperthyroidism. The most appropriate management is to withhold the biotin-containing supplement for 2 to 7 days to allow for clearance, followed by repeat testing.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and physical examination.
The patient is completely asymptomatic with normal vital signs and a benign physical exam, indicating a clinically euthyroid state.
Clinical presentation must anchor the interpretation of laboratory results.
2
Evaluate the laboratory findings.
Labs show a suppressed TSH alongside elevated free T4 and T3, a classic biochemical pattern for primary hyperthyroidism.
Identifying the biochemical pattern is necessary to compare against the clinical picture.
3
Reconcile the clinical state with the biochemical pattern.
There is a stark discrepancy between the patient's normal euthyroid clinical state and her severe hyperthyroid laboratory pattern.
Extreme discrepancies between symptoms and lab values should raise immediate suspicion for assay interference or an alternate non-pathologic etiology.
4
Identify potential sources of laboratory interference based on the patient's history.
The patient recently began taking a hair and nail supplement, which frequently contains very high doses of exogenous biotin (vitamin B7).
Biotin strongly interferes with streptavidin-biotin immunoassays commonly used for thyroid testing, creating a profile that mimics primary hyperthyroidism.
5
Determine the most appropriate management.
The correct action is to eliminate the source of interference by stopping the biotin supplement and repeating the tests after 2 to 7 days.
Removing the interfering agent confirms the artifactual nature of the lab results and prevents unnecessary, potentially harmful medical interventions.

Anahtar Kavram

Biotin-induced interference in thyroid function testing
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Endocrinology and Metabolism

Bu konudan daha fazla soru